linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Glaxosmithkline Pharmaceuticals Ltd.
 
Source DateBoard Meeting DateDetails
22 Apr 202613 May 2026 Audited Results & Dividend
06 Jan 202609 Feb 2026 Quarterly Results
27 Oct 202506 Nov 2025 Quarterly Results
04 Jul 202501 Aug 2025 Quarterly Results
17 Apr 202513 May 2025 Final Dividend & Audited Results
20 Jan 202510 Feb 2025 Quarterly Results(Cancelled) (Cancelled)
20 Jan 202514 Feb 2025 Quarterly Results
15 Jan 202510 Feb 2025 Quarterly Results
24 Oct 202429 Oct 2024 Interim Dividend & Quarterly Results
18 Jul 202402 Aug 2024 Quarterly Results
19 Apr 202417 May 2024 Audited Results & Final Dividend
04 Jan 202412 Feb 2024 Quarterly Results
04 Oct 202309 Nov 2023 Quarterly Results
30 Jun 202326 Jul 2023 Quarterly Results
03 May 202317 May 2023 Final Dividend & Audited Results
11 Jan 202307 Feb 2023 Quarterly Results
31 Oct 202211 Nov 2022 Quarterly Results
28 Jun 202225 Jul 2022 Quarterly Results
02 May 202216 May 2022 Audited Results & Dividend
28 Dec 202107 Feb 2022 Quarterly Results
Page 1 of 6
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.